welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
not yet recruiting

Prognostic Factors Affecting Duchenne Muscular Dystrophy

key information

study id #: NCT03372655

condition: Duchenne Muscular Dystrophy

status: not yet recruiting


Determination of prognostic factors affecting ambulation of duchenne muscular dystrophy

mechanism of action: No pharmaceutical intervention

results: https://clinicaltrials.gov/ct2/show/results/NCT03372655

last updated: November 18, 2019

study details

start date: January 1, 2018

estimated completion: January 1, 2019

size / enrollment: 82

study description:
Duchenne muscular dystrophy is the most common herditary muscular disease , it lead to loss of ambulation in early teenageers . It lead to early death at the mean age of 19 years

primary outcomes:

  • Ten meter walking test [Time Frame: 2018 - 2019]

secondary outcomes:

  • Muscle strength [Time Frame: 2018- 2019]

inclusion criteria:

• Eligible Ages: 10 - 18
• Eligible Sexes: male

Any male pt diagnosed as Duchenne muscular dystrophy by typical clinical picture & shooting serum CPK level & EMG study or biopsy & age 10 to 18yrs old

exclusion criteria:
Female patient' age below 10 yrs old or above 18 yrs old. Patient with autoimmune disease or malignancy.

study contacts

sponsor: Assiut University

contacts: Nehal Refaat, 0-100-024-2438, nehalrefaatmohammed@gmail.com